On July 30, Align Technology declined 8.14% overnight, trading at $165.42/share, with turnover of $38,600.
The decline was triggered by the company's Q3 revenue guidance falling short of expectations despite a modest Q2 earnings beat. Align reported Q2 adjusted EPS of $2.64, up 6% year-over-year, slightly exceeding the consensus estimate of $2.61. Revenue came in at $1.056 billion, up approximately 5% year-over-year, also marginally above the $1.052 billion estimate. However, the company guided Q3 revenue of $1.0 billion to $1.02 billion, positioned at the low end of analyst expectations of $1.02 billion. Full-year revenue growth guidance was set at just 3% to 4%, signaling decelerating momentum in the second half.
Additionally, an unresolved EU antitrust investigation into Invisalign clear aligners and intraoral scanners, the departure of the Chief Legal Officer, and ongoing governance changes following activist Elliott Investment Management's engagement — including the appointment of three new board directors — collectively weighed on market sentiment.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments